Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Division of Structural Biology, Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine have visualised the full membrane fusion process of SARS-CoV-2 under near-native conditions, capturing elusive intermediate states that occur as the virus enters host cells. Published in Nature Communications, the study presents a comprehensive structural timeline of how the viral spike protein drives fusion and how this process can be blocked by S2-targeting neutralising antibodies.

The team, led by Professor Peijun Zhang, Professor of Structural Biology and Director of the Electron Bioimaging Centre at Diamond Light Source, and Dr Caner Akil, Senior Postdoctoral Researcher and first author of the study, developed a functional viral fusion system and applied in situ cryo-electron tomography to directly observe the full range of viral fusion intermediates. Their findings reveal how the spike protein progresses through extended, partially folded, and fully folded conformations before forming a fusion pore. This sequence is tightly regulated by protease cleavage and receptor binding.

Professor Peijun Zhang said: “Our fusion system provides a comprehensive perspective on spike–ACE2 and spike–antibody interactions, capturing the complete spectrum of fusion intermediates, including many previously unrecognised states, and offers a platform for the development of next-generation fusion inhibitors.”

Dr Caner Akıl added: “This study not only advances our understanding of SARS-CoV-2 fusion mechanisms and the inhibitory action of S2-targeting antibodies, but also holds promise for investigating membrane fusion across a wide range of viral systems.”

Crucially, the study demonstrates how the WS6 S2 antibody binds and clusters prefusion spikes, crosslinking them and preventing the conformational changes required for membrane fusion. These insights deepen our understanding of coronavirus entry and point to promising new strategies for the development of pan-coronavirus antiviral therapies.

 

Akıl C, Xu J, Shen J, Zhang P. Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET. Nat Commun. 2025 Jun 3;16(1):5150.  doi: 10.1038/s41467-025-60406-z.